Press Releases

Date	Title	Company
20-Feb-2023	Pupillometer Market to Reach US$ 809.56 Million by the year 2033 Due to Rise in People with Eye Problems	MARKITWIRED
20-Feb-2023	Wheelchairs Market Growth Accelerating with Rising Developments in Assistive Technologies: Future Market Insights	MARKITWIRED
20-Feb-2023	Rise in Cosmetic Dentistry is expected to propel the Growth of the Teeth Whitening Market \| Future Market Insights	MARKITWIRED
19-Feb-2023	Takeda Presents Positive Results from Phase 3 Study of Vedolizumab for Prevention of Intestinal Acute Graft-Versus-Host Disease (aGvHD) in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)	Businesswire
18-Feb-2023	Ligand’s Partner Travere Therapeutics Announces FDA Accelerated Approval of FILSPARI™ (sparsentan), the First and Only Non-immunosuppressive Therapy for the Reduction of Proteinuria in IgA Nephropathy	Businesswire
18-Feb-2023	Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of AUSTEDO® (deutetrabenazine) Tablets	Businesswire
17-Feb-2023	Napoli Shkolnik Files Complaint Against Manufacturers of Artificial Tear Products Linked to Bacterial Infections	Businesswire
17-Feb-2023	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Kornit Digital Ltd. (KRNT) on Behalf of Investors	Businesswire
17-Feb-2023	Genomic Vision announces the issuance of the 2nd tranche of convertible notes with warrants (OCABSA) for €2 million, as part of the financing line concluded with Winance for a maximum amount of €30 million	Businesswire
17-Feb-2023	Adjuvant Opdivo (nivolumab) Continues to Provide Significant, Durable Clinical Benefits for Patients with Radically Resected, High-Risk Muscle-Invasive Urothelial Carcinoma After Three Years in CheckMate -274 Trial	Businesswire
17-Feb-2023	Understanding the Scope of Pharmacovigilance Courses	TechnoBridge Systems
17-Feb-2023	Bio-Rad to Participate in Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference	Businesswire
17-Feb-2023	Rosai-Dorfman Disease Therapeutics Market is expected to grow with a 6.9% CAGR during 2023 to 2033	MARKITWIRED
17-Feb-2023	Whim Syndrome Management Market is expected to reach US$ 17.91 Million by 2033	MARKITWIRED
17-Feb-2023	Atypical Hemolytic Uremic Syndrome Treatment Market to Register 4.9% CAGR from 2023 to 2033	MARKITWIRED
17-Feb-2023	Equillium Announces Oral Presentation at the Tandem Meetings of ASTCT and CIBMTR	Businesswire
17-Feb-2023	Cell and Gene Therapy Manufacturing Market is projected to increase at a CAGR 29% from 2023 to 2033	MARKITWIRED
17-Feb-2023	Clinical Trials Market is expected to reach US$ 177.7 Billion by 2033	MARKITWIRED
17-Feb-2023	Viral Vector Development Market to Reach US$ 4.1 Billion Valuation by 2033	MARKITWIRED
17-Feb-2023	U.S. FDA Accepts for Priority Review the Supplemental New Drug Application for Merck’s PREVYMIS™ for Prophylaxis of Cytomegalovirus Disease in Kidney Transplant Recipients at High Risk	Businesswire